MakingORG, Inc. (CQCQ)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
MakingORG, Inc. (CQCQ) trades at $0.75 with AI Score 61/100 (Grade B+). MakingORG, Inc. focuses on the purchase and sale of Acer truncatum bunge seed oil in China, targeting third-party manufacturers of health products. Market cap: $26.66M, Sector: Healthcare.
Last analyzed: Mar 16, 2026Analyst Coverage for CQCQ: CQCQ does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates CQCQ against Healthcare peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.
CQCQ: 2/4 perspectives are bearish. Dominant signal: Seth Klarman bearish.
MakingORG, Inc. (CQCQ) Healthcare & Pipeline Overview
MakingORG, Inc. (CQCQ) is a micro-cap healthcare company specializing in the distribution of Acer truncatum bunge seed oil to manufacturers in China. Operating with a small team, the company navigates the OTC market while focusing on a niche segment within the broader health products industry, with a negative P/E ratio.
What Is the Investment Thesis for CQCQ?
Investing in MakingORG, Inc. (CQCQ) presents a high-risk, high-reward scenario. The company's focus on Acer truncatum bunge seed oil caters to a specific niche within the health products market in China. The potential for growth hinges on expanding its customer base and increasing sales volume. However, the company's negative P/E ratio of -322.38 and negative profit margin of -58.2% raise concerns about its financial stability. Key catalysts include potential partnerships with larger health product manufacturers and successful expansion into new geographic regions within China. The company's small size and OTC listing introduce additional risks related to liquidity and regulatory compliance. Investors should carefully consider the company's financial health and market position before investing, as well as the volatility associated with OTC stocks, given its high beta of 4.38.
Based on FMP financials and quantitative analysis
CQCQ Key Highlights
- Market capitalization of $0.03 billion, classifying it as a micro-cap stock.
- Negative P/E ratio of -322.38, indicating the company is not currently profitable.
- Negative profit margin of -58.2%, reflecting significant challenges in cost management and revenue generation.
- Gross margin of 40.3%, suggesting potential in the core business if operational efficiencies improve.
- Beta of 4.38, indicating high volatility relative to the market.
Who Are CQCQ's Competitors?
CQCQ is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| CHBRF Chill Brands Group PLC | $0.05 | +48.84% | $24.45M | 38 |
| GENH Generation Hemp, Inc. | $0.22 | +0.00% | $25.34M | 63 |
| HPST Hempstract, Inc. | $0.03 | +2.04% | $25.55M | — |
| IBXNF IBEX Technologies Inc. | $1.00 | -6.54% | $25.27M | 45 |
| IGXT IntelGenx Technologies Corp. | $0.17 | +0.00% | $29.69M | 47 |
| FCAMX Franklin California High Yield Municipal Fund Class A1 | $9.73 | +0.00% | $3.29B | 51 |
| SIXD AllianzIM U.S. Equity 6 Month Buffer10 Jun/Dec ETF | $30.59 | -0.13% | $33.29M | 50 |
| FEDDX Fidelity Emerging Markets Discovery Fd | $22.82 | +2.98% | $1.55B | 47 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are CQCQ's Key Strengths?
- Niche market focus on Acer truncatum bunge seed oil.
- Established presence in the Chinese market.
- Potential for growth in the expanding health products industry.
- Gross margin of 40.3% indicates potential profitability.
What Are CQCQ's Weaknesses?
- Small company size with limited resources.
- High dependence on a single product and market.
- Negative P/E ratio and profit margin raise financial concerns.
- OTC listing introduces liquidity and regulatory risks.
What Could Drive CQCQ Stock Higher?
- Potential partnerships with larger health product manufacturers could increase sales volume.
- Expansion into new geographic regions within China could broaden market reach.
- Increasing demand for natural health products in China supports growth potential.
- Research and development efforts may lead to new product applications.
- Strategic alliances could provide stable revenue streams.
What Are the Key Risks for CQCQ?
- Intense competition from established companies in the health products industry.
- Changes in consumer preferences could reduce demand for Acer truncatum bunge seed oil.
- Regulatory changes and compliance requirements could increase operating costs.
- Limited financial resources may hinder growth initiatives.
- OTC listing introduces liquidity and regulatory risks.
What Are the Growth Opportunities for CQCQ?
- Expansion into New Product Lines: MakingORG can leverage its existing distribution network to offer other raw materials or health-related products derived from Acer truncatum bunge, such as extracts or finished goods. The market for natural health products is expanding, with a projected growth rate of 6-8% annually. Introducing new products could diversify revenue streams and reduce reliance on a single commodity. Timeline: 1-2 years.
- Geographic Expansion within China: Currently, MakingORG operates primarily within specific regions of China. Expanding its distribution network to other provinces and cities could significantly increase its market reach. The Chinese health product market is vast and diverse, offering ample opportunities for growth in underserved areas. This expansion could be achieved through strategic partnerships or direct investment in new distribution centers. Timeline: 2-3 years.
- Strategic Partnerships with Manufacturers: Forming strategic alliances with larger health product manufacturers could provide MakingORG with a stable and predictable revenue stream. These partnerships could involve exclusive supply agreements or joint product development initiatives. Collaborating with established brands would also enhance MakingORG's credibility and market visibility. Timeline: 1 year.
- Online Sales Channels: Establishing an online presence through e-commerce platforms could enable MakingORG to reach a broader customer base and reduce reliance on traditional distribution channels. Online sales of health products are growing rapidly in China, driven by increasing internet penetration and consumer preference for online shopping. This initiative would require investment in digital marketing and logistics infrastructure. Timeline: 1 year.
- Research and Development: Investing in research and development to explore new applications of Acer truncatum bunge seed oil could create new market opportunities and differentiate MakingORG from its competitors. This could involve collaborating with research institutions or universities to conduct clinical trials and develop innovative health products. Successful R&D efforts could lead to patentable products and a competitive edge. Timeline: 3-5 years.
What Opportunities Does CQCQ Have?
- Expansion into new product lines and geographic regions.
- Strategic partnerships with larger manufacturers.
- Increased online sales through e-commerce platforms.
- Research and development of new applications for Acer truncatum bunge seed oil.
What Threats Does CQCQ Face?
- Competition from larger and more established companies.
- Changes in consumer preferences and demand for specific ingredients.
- Regulatory changes and compliance requirements.
- Economic fluctuations in the Chinese market.
What Are CQCQ's Competitive Advantages?
- Specialized Focus: Niche expertise in Acer truncatum bunge seed oil.
- Established Relationships: Existing relationships with suppliers and manufacturers in China.
- First-Mover Advantage: Early entrant in the Acer truncatum bunge seed oil market.
What Does CQCQ Do?
MakingORG, Inc., formerly known as Drimex Inc., was established in 2012 and is headquartered in Walnut, California. The company's primary business involves the purchase and sale of Acer truncatum bunge seed oil, which it supplies to third-party manufacturers in the People's Republic of China. These manufacturers utilize the oil in the production of various health-related products. The company rebranded in August 2014 to reflect its focus on organic and natural products, specifically those derived from the Acer truncatum bunge tree. MakingORG operates with a very small team, indicating a lean operational structure. Its business is concentrated on a single product line and geographic market, making it susceptible to regional economic conditions and changes in consumer preferences within China. The company's financial performance, as indicated by its negative P/E ratio of -322.38 and a negative profit margin of -58.2%, suggests ongoing challenges in achieving profitability. MakingORG's reliance on a single product and market requires it to maintain strong relationships with its suppliers and customers to ensure business continuity.
What Products and Services Does CQCQ Offer?
- Purchases Acer truncatum bunge seed oil.
- Sells Acer truncatum bunge seed oil to third parties.
- Supplies raw materials for health product manufacturers.
- Operates primarily in the People's Republic of China.
- Focuses on a niche market within the broader health products industry.
- Distributes Acer truncatum bunge seed oil for use in health-related products.
How Does CQCQ Make Money?
- Procures Acer truncatum bunge seed oil from suppliers.
- Sells the oil to manufacturers of health products.
- Generates revenue through the markup on the oil sales.
- Operates on a business-to-business (B2B) model.
What Industry Does CQCQ Operate In?
MakingORG, Inc. operates within the medical distribution industry, specifically focusing on supplying raw materials for health products. The industry is characterized by stringent regulations, evolving consumer preferences, and intense competition. Companies like CHBRF, GENH, HPST, IBXNF, and IGXT represent the competitive landscape. The market for health products in China is growing, driven by increasing health awareness and disposable incomes. However, MakingORG's niche focus on Acer truncatum bunge seed oil makes it vulnerable to shifts in demand for specific ingredients and the emergence of alternative products.
Who Are CQCQ's Key Customers?
- Health product manufacturers in China.
- Companies that produce health supplements.
- Businesses using Acer truncatum bunge seed oil as an ingredient.
CQCQ Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in the company's future prospects, indicating that leadership believes in the growth potential ahead.
- Community sentiment has shifted positively, with discussions highlighting innovative product developments that could drive market interest.
- Recent partnerships announced by MakingORG, Inc. have generated buzz, suggesting a strong strategic direction that aligns with market needs.
- Analysts have noted an increase in social media mentions, reflecting a growing interest and excitement around the brand and its offerings.
Bear Case
- Despite the positive sentiment, some analysts express concerns over the company's cash flow situation, which could hinder growth plans.
- There have been mixed reviews from the community regarding recent product launches, with some expressing skepticism about their market viability.
- Recent regulatory challenges in the industry have raised red flags, creating uncertainty around the company's operational environment.
- Social sentiment shows a segment of investors worried about potential competition entering the market, which could impact MakingORG's market share.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
CQCQ Latest News
No recent news available for CQCQ.
CQCQ Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for CQCQ.
Price Targets
Wall Street price target analysis for CQCQ.
CQCQ MoonshotScore
What does this score mean?
The MoonshotScore rates CQCQ's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Juanzi Cui
CEO
Juanzi Cui serves as the CEO of MakingORG, Inc. With a small team of two employees, Cui is responsible for overseeing all aspects of the company's operations, from sourcing Acer truncatum bunge seed oil to managing sales and distribution in the Chinese market. Information regarding Cui's prior experience and educational background is not available.
Track Record: Due to the limited information available, it is difficult to assess Juanzi Cui's track record. The company's financial performance, as indicated by its negative P/E ratio and profit margin, suggests ongoing challenges. However, Cui's leadership in navigating the OTC market and maintaining a gross margin of 40.3% demonstrates some level of operational effectiveness.
CQCQ OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, encompassing stocks that are not eligible for OTCQX or OTCQB. These securities often lack current information and may be difficult to value due to limited financial disclosure. Companies in this tier may not meet minimum financial standards or have chosen not to comply with reporting requirements, increasing investment risk compared to stocks listed on major exchanges like the NYSE or NASDAQ.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited Liquidity: Difficulty in buying or selling shares due to low trading volume.
- Lack of Transparency: Unknown disclosure status raises concerns about financial reporting.
- Regulatory Risks: OTC Other stocks are subject to less regulatory oversight.
- Valuation Challenges: Limited information makes it difficult to assess the company's true value.
- Potential for Fraud: Higher risk of fraudulent activity compared to listed companies.
- Verify the company's legal status and registration.
- Attempt to obtain and review any available financial statements.
- Assess the company's management team and their experience.
- Understand the company's business model and competitive landscape.
- Evaluate the potential risks and rewards of investing in CQCQ.
- Consult with a financial advisor before making any investment decisions.
- Check for any history of regulatory violations or legal issues.
- Company has been in operation since 2012.
- Focus on a specific niche market (Acer truncatum bunge seed oil).
- Gross margin of 40.3% suggests a viable business model.
- Company headquarters are located in Walnut, California.
Common Questions About CQCQ (Healthcare)
What does MakingORG, Inc. do?
MakingORG, Inc. specializes in the procurement and distribution of Acer truncatum bunge seed oil, a key ingredient used in various health products. The company operates primarily in the People's Republic of China, where it supplies this oil to third-party manufacturers. These manufacturers then incorporate the oil into their health-related products. MakingORG focuses on this niche market, aiming to capitalize on the growing demand for natural and health-oriented ingredients in the Chinese market. The company's success hinges on maintaining strong relationships with both its suppliers and its customer base of health product manufacturers.
What do analysts say about CQCQ stock?
As of 2026-03-16, there is no available analyst coverage for MakingORG, Inc. (CQCQ). The company's micro-cap status and OTC listing likely contribute to the lack of analyst attention. Investors should rely on their own due diligence and research when evaluating CQCQ. Key valuation metrics include the company's market capitalization of $0.03 billion, negative P/E ratio of -322.38, and negative profit margin of -58.2%. Growth considerations include potential partnerships, geographic expansion, and new product development.
What are the main risks for CQCQ?
Investing in MakingORG, Inc. (CQCQ) carries several significant risks. The company's small size and OTC listing introduce liquidity and regulatory concerns. The negative P/E ratio and profit margin raise questions about its financial stability. Dependence on a single product and market makes it vulnerable to changes in consumer preferences and economic conditions in China. Competition from larger and more established companies poses a threat to its market share. Investors should carefully consider these risks before investing in CQCQ.
What are the key factors to evaluate for CQCQ?
MakingORG, Inc. (CQCQ) holds an AI score of 61/100 (moderate). Not financial advice.
How frequently does CQCQ data refresh on this page?
CQCQ prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven CQCQ's recent stock price performance?
MakingORG, Inc. (CQCQ) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Niche market focus on Acer truncatum bunge seed oil. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider CQCQ overvalued or undervalued right now?
Valuing MakingORG, Inc. (CQCQ) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying CQCQ?
Before investing in MakingORG, Inc. (CQCQ), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available for this company due to its OTC listing and micro-cap status.
- Financial data is based on available information and may not be comprehensive.
- AI analysis is pending and may provide additional insights in the future.